PAD Screening Guidelines: Prevent Complications
- An international coalition of cardiologists, angiologists, and vascular surgeons is advocating for routine screening to help prevent complications linked to peripheral arterial disease (PAD).
- PAD, a prevalent condition, involves the accumulation of deposits in the arteries, which restricts blood flow to leg muscles.
- Updated European Society of Cardiology (ESC) guidelines,with contributions from University of Surrey researchers,emphasize that personalized treatment plans—potentially including a simple walking program and a healthy diet—could benefit nearly...
New guidelines on peripheral arterial disease (PAD) screening strongly advocate for early detection to safeguard heart health.These updated recommendations from a global panel of experts emphasize the crucial role of regular screening for PAD, a condition often asymptomatic yet linked to severe health risks. Early diagnosis and personalized treatment plans are now the cornerstone to reduce the potentials for heart attack, stroke, and limb amputation. This entails tailored interventions,including diet adjustments,exercise programs,and the potential use of mobile apps for managing PAD effectively,benefiting an estimated 300 million worldwide. News Directory 3 recognizes the importance of lipid-lowering treatments and efficient management of blockages.Discover what innovative approaches, including advanced diagnostic methods, are helping prevent future complications.
PAD Screening Guidelines Urge Early Detection for Heart Health
Updated June 10, 2025
An international coalition of cardiologists, angiologists, and vascular surgeons is advocating for routine screening to help prevent complications linked to peripheral arterial disease (PAD).
PAD, a prevalent condition, involves the accumulation of deposits in the arteries, which restricts blood flow to leg muscles. While many individuals with PAD remain asymptomatic, some may experience leg pain during walking that subsides after a few minutes of rest. Even though PAD stems from blocked arteries in the legs, it frequently enough signals early artery blockages in the brain and heart. Early detection and treatment of PAD substantially lowers the risk of serious conditions like amputations, heart attacks, and strokes.
Updated European Society of Cardiology (ESC) guidelines,with contributions from University of Surrey researchers,emphasize that personalized treatment plans—potentially including a simple walking program and a healthy diet—could benefit nearly 300 million people globally who live with PAD. the guidelines also endorse a novel, more reliable method developed at Surrey for detecting PAD, known as the estimated ankle brachial pressure index.
The guidelines further promote using mobile apps to help manage PAD and ensure patient adherence to their personalized treatment plans. These strategies aim to improve peripheral arterial disease (PAD) management and reduce the risk of complications.
“these updated guidelines are important because they provide a roadmap for preventing and managing serious complications in people with peripheral arterial disease.By focusing on early detection, personalised treatment plans, lifestyle changes and early revascularisation, if required, we can significantly improve patient outcomes and quality of life. Combined with advances in diagnostic methods, medical apps and wearable monitoring devices, our work equips patients and their caregivers with the tools and knowledge to take control of their health and prevent future issues,”
The guidelines also underscore the importance of lipid-lowering treatments to decrease “bad” cholesterol (LDL) levels in the blood. These treatments help prevent fatty buildups in arteries that can obstruct blood flow. The guidelines advise aiming for very low LDL cholesterol levels to better protect the heart and blood vessels, a key aspect of PAD screening.
If lifestyle adjustments, such as diet and exercise, along with standard medications like statins, are insufficient to lower cholesterol, the guidelines suggest additional treatments. These include PCSK9 inhibitors, which can substantially reduce LDL cholesterol for individuals struggling to meet their targets with statins alone, and bempedoic acid, an choice for those who cannot tolerate statins or require extra support in lowering their cholesterol levels. These treatments are crucial for managing peripheral arterial disease effectively.
Moreover, the guidelines highlight the critical role of early and efficient treatment of blockages, frequently enough achievable with catheters, thus avoiding the need for surgery.
What’s next
The medical community anticipates wider adoption of these guidelines to improve early detection and personalized management strategies for individuals at risk of or affected by PAD, ultimately aiming to reduce the incidence of severe complications.